Day 1 from Vienna 2026

Redefining Diabetic Retinopathy: EURETINA Experts Highlight AI Screening, Novel Drug Delivery, and Early Neurodegeneration

Speakers in Thursday afternoon’s Euretina session on diabetic retinopathy (DR) and diabetic macular oedema (DMO) covered a range of topics that included screening and early detection of DR, novel methods for treatment delivery and applications for imaging techniques.

Redefining Diabetic Retinopathy: EURETINA Experts Highlight AI Screening, Novel Drug Delivery, and Early Neurodegeneration Read More »

Eye Openers: Master Surgeons Share Hard-Won Lessons and Surgical Rescue Strategies

The Euretina Session track at the 2026 Congress began on Thursday morning with a programme titled “Eye Openers”. In this video-based interactive session, six experienced retina specialists presented lessons learned from challenging vitreoretinal surgery cases. At junctures when complications occurred throughout the cases, input on next steps was sought from a faculty panel and audience members equipped with electronic response keypads.

Eye Openers: Master Surgeons Share Hard-Won Lessons and Surgical Rescue Strategies Read More »

Elevating Science: Explore the Revamped Free Paper Forums and Poster Hub

At the beginning of her keynote address on Artificial Intelligence (AI) in Medicines Development: Perspective From an EU Medicines Regulator, Jane Moseley, Senior Scientific Officer at the European Medicines Agency (EMA) said she would be addressing three key questions: Where do we want to get to with AI in medicines development?; Where are we now?; and How are we going to get there?

Elevating Science: Explore the Revamped Free Paper Forums and Poster Hub Read More »

Bridging Innovation and Approval: EMA Regulators Outline the Future of Ophthalmic Development

Taking place Thursday, 1 October, from 15:00 to 16:00 CEST in Room 4, this 60-minute symposium, chaired by Hemme Hijma and Elisabeth Wischnitzki, covers basic principles and current clinical and methodological topics in EU medicines regulation as applied directly to ophthalmology. 

Bridging Innovation and Approval: EMA Regulators Outline the Future of Ophthalmic Development Read More »